We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

133 hedge funds and large institutions have $248M invested in Olema Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 43 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

15% less funds holding

Funds holding: 156 → 133 (-23)

27.95% less ownership

Funds ownership: 124.4% → 96.44% (-28%)

40% less capital invested

Capital invested by funds: $415M → $248M (-$167M)

49% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 47

79% less call options, than puts

Call options by funds: $27K | Put options by funds: $128K

Holders
133
Holders Change
-23
Holders Change %
-14.74%
% of All Funds
1.78%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
48
Reduced
43
Closed
47
Calls
$27K
Puts
$128K
Net Calls
-$101K
Net Calls Change
-$1.83M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$13.8M
2
UBS Group
UBS Group
Switzerland
+$2.97M
3
PC
Pier Capital
Connecticut
+$2.74M
4
Goldman Sachs
Goldman Sachs
New York
+$1.8M
5
AAA
Affinity Asset Advisors
New York
+$1.63M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$11.2M
2
ACA
Avoro Capital Advisors
New York
-$9.63M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5.1M
4
State Street
State Street
Massachusetts
-$4.99M
5
BCM
Boxer Capital Management
California
-$3.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
Schroder Investment Management Group
26
Schroder Investment Management Group
United Kingdom
$2.19M – – –
Morgan Stanley
27
Morgan Stanley
New York
$1.7M -$2.88M -572,786 -56%
Northern Trust
28
Northern Trust
Illinois
$1.57M -$28.7K -5,702 -1%
Ameriprise
29
Ameriprise
Minnesota
$1.5M -$251K -49,899 -11%
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$1.38M +$877K +174,356 +90%
Charles Schwab
31
Charles Schwab
California
$1.31M +$80.8K +16,073 +5%
N
32
Nuveen
North Carolina
$1.29M +$1.14M +225,862 +191%
AAA
33
Affinity Asset Advisors
New York
$1.22M +$1.63M +325,000 New
Marshall Wace
34
Marshall Wace
United Kingdom
$1.2M +$639K +127,007 +66%
JP Morgan Chase
35
JP Morgan Chase
New York
$1.08M +$635K +126,182 +78%
HWAM
36
Hennion & Walsh Asset Management
New Jersey
$912K +$152K +30,240 +14%
HS
37
HighVista Strategies
Massachusetts
$798K – – –
IC
38
Ikarian Capital
Texas
$722K +$503K +100,000 +109%
SFI
39
Susquehanna Fundamental Investments
Pennsylvania
$660K +$827K +164,472 +1,498%
Barclays
40
Barclays
United Kingdom
$576K +$192K +38,225 +33%
Jane Street
41
Jane Street
New York
$521K +$477K +94,815 +217%
Two Sigma Advisers
42
Two Sigma Advisers
New York
$519K +$246K +49,000 +55%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$496K +$16.7K +3,328 +3%
Balyasny Asset Management
44
Balyasny Asset Management
Illinois
$425K -$5.1M -1,014,571 -90%
DIA
45
Dana Investment Advisors
Wisconsin
$425K +$105K +20,915 +23%
DP
46
Diadema Partners
New Jersey
$376K +$503K +100,000 New
CSS
47
Cubist Systematic Strategies
Connecticut
$352K +$340K +67,682 +260%
Victory Capital Management
48
Victory Capital Management
Texas
$347K -$3.97K -790 -0.8%
Walleye Capital
49
Walleye Capital
New York
$330K +$104K +20,698 +31%
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
$282K – – –
1
2
3 4 5

OLMA Hedge Fund Activity: Q1 2025 in Review

133 of the 7,460 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q1 2025, worth a combined $248M — down 40% from $415M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of OLMA and 24 opened new positions — a net loss of 23 holders — while 43 trimmed existing stakes and 48 added.

The largest buyer was Franklin Resources, adding an estimated $13.8M. The largest seller was Point72 Asset Management, cutting an estimated $11.2M.

  • 133 institutional investors held Olema Pharmaceuticals (OLMA) as of Q1 2025, down from 156 in Q4 2024.
  • Funds reported $248M of Olema Pharmaceuticals stock for Q1 2025, down 40% quarter-over-quarter.
  • 24 funds opened new Olema Pharmaceuticals positions in Q1 2025 and 47 closed out, a net change of -23 holders.
  • The largest Olema Pharmaceuticals buyer in Q1 2025 was Franklin Resources, an estimated $13.8M added.
  • The largest Olema Pharmaceuticals seller in Q1 2025 was Point72 Asset Management, an estimated $11.2M sold.

Based on aggregated 13F filings for Q1 2025.